All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
AKRO / Akero Therapeutics, Inc.
|
|
|
|
|
|
|
|
TNDM / Tandem Diabetes Care, Inc.
|
|
|
|
|
|
|
|
RVMD / Revolution Medicines, Inc.
|
|
|
|
|
|
|
|
CNC / Centene Corporation
|
|
|
|
|
|
|
|
CABA / Cabaletta Bio, Inc.
|
|
|
|
|
|
|
|
TCRR / Tcr2 Therapeutics Inc
|
|
|
|
|
|
|
|
QURE / uniQure N.V.
|
|
|
|
|
|
|
|
PTCT / PTC Therapeutics, Inc.
|
|
|
|
|
|
|
|
AMED / Amedisys, Inc.
|
|
|
|
|
|
|
|
BOLD / Boundless Bio, Inc.
|
|
|
|
|
|
|
|
FATE / Fate Therapeutics, Inc.
|
|
|
|
|
|
|
|
GH / Guardant Health, Inc.
|
|
|
|
|
|
|
|
CYRX / Cryoport, Inc.
|
|
|
|
|
|
|
|
OVID / Ovid Therapeutics Inc.
|
|
|
|
|
|
|
|
PPD / PPD Inc
|
|
|
|
|
|
|
|
ODT / Odonate Therapeutics Inc
|
|
|
|
|
|
|
|
GLYC / GlycoMimetics, Inc.
|
|
|
|
|
|
|
|
GTHX / G1 Therapeutics, Inc.
|
|
|
|
|
|
|
|
US29266S3040 / Endologix, Inc.
|
|
|
|
|
|
|
|
US74257L1089 / Principia Biopharma Inc.
|
|
|
|
|
|
|
|
MRK / Merck & Co., Inc.
|
|
|
|
|
|
|
|
GOSS / Gossamer Bio, Inc.
|
|
|
|
|
|
|
|
CSLT / Castlight Health Inc - Class B
|
|
|
|
|
|
|
|
NVRO / Nevro Corp.
|
|
|
|
|
|
|
|
TWST / Twist Bioscience Corporation
|
|
|
|
|
|
|
|
US60877T1007 / Momenta Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
NVS / Novartis AG - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
TCDA / Tricida Inc
|
|
|
|
|
|
|
|
FOLD / Amicus Therapeutics, Inc.
|
|
|
|
|
|
|
|
BIIB / Biogen Inc.
|
|
|
|
|
|
|
|
SYRS / Syros Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
VAPO / Vapotherm, Inc.
|
|
|
|
|
|
|
|
US69354M1080 / PRA Health Sciences Inc
|
|
|
|
|
|
|
|
AXNX / Axonics, Inc.
|
|
|
|
|
|
|
|
PROF / Profound Medical Corp.
|
|
|
|
|
|
|
|
US28249H1041 / Eidos Therapeutics, Inc.
|
|
|
|
|
|
|
|
110122157 / Bristol Meyers Squibb CVR Exp. 12/31/2020
|
|
|
|
|
|
|
|
ONEM / 1life Healthcare Inc
|
|
|
|
|
|
|
|
HCA / HCA Healthcare, Inc.
|
|
|
|
|
|
|
|
CI / The Cigna Group
|
|
|
|
|
|
|
|
PAYX / Paychex, Inc.
|
|
|
|
|
|
|
|
EPZM / Epizyme Inc
|
|
|
|
|
|
|
|
GMXAY / Genmab A/S
|
|
|
|
|
|
|
|
ADPT / Adaptive Biotechnologies Corporation
|
|
|
|
|
|
|
|
FTSV / Forty Seven, Inc.
|
|
|
|
|
|
|
|
CLVS / Clovis Oncology Inc
|
|
|
|
|
|
|
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
|
|
|
|
|
|
APRE / Aprea Therapeutics, Inc.
|
|
|
|
|
|
|
|
ARGX / argenx SE - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
UNH / UnitedHealth Group Incorporated
|
|
|
|
|
|
|
|
SGEN / Seagen Inc
|
|
|
|
|
|
|
|
SWAV / Shockwave Medical, Inc.
|
|
|
|
|
|
|
|
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ZYME / Zymeworks Inc.
|
|
|
|
|
|
|
|
WVE / Wave Life Sciences Ltd.
|
|
|
|
|
|
|
|
CBAY / CymaBay Therapeutics, Inc.
|
|
|
|
|
|
|
|
DCPH / Deciphera Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
DXCM / DexCom, Inc.
|
|
|
|
|
|
|
|
REPL / Replimune Group, Inc.
|
|
|
|
|
|
|
|
KRYS / Krystal Biotech, Inc.
|
|
|
|
|
|
|
|
STOK / Stoke Therapeutics, Inc.
|
|
|
|
|
|
|
|
BMY / Bristol-Myers Squibb Company
|
|
|
|
|
|
|
|
ALLK / Allakos Inc.
|
|
|
|
|
|
|
|
IMGN / ImmunoGen, Inc.
|
|
|
|
|
|
|
|
XERS / Xeris Biopharma Holdings, Inc.
|
|
|
|
|
|
|
|
HOOK / HOOKIPA Pharma Inc.
|
|
|
|
|
|
|
|
BSX / Boston Scientific Corporation
|
|
|
|
|
|
|
|
ELV / Elevance Health, Inc.
|
|
|
|
|
|
|
|
BEAM / Beam Therapeutics Inc.
|
|
|
|
|
|
|
|
RGNX / REGENXBIO Inc.
|
|
|
|
|
|
|
|
CTLT / Catalent, Inc.
|
|
|
|
|
|
|
|
ARDX / Ardelyx, Inc.
|
|
|
|
|
|
|
|
STXS / Stereotaxis, Inc.
|
|
|
|
|
|
|
|
BCEL / Atreca, Inc.
|
|
|
|
|
|
|
|
ATRA / Atara Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
SRRK / Scholar Rock Holding Corporation
|
|
|
|
|
|
|
|
IGMS / IGM Biosciences, Inc.
|
|
|
|
|
|
|
|
GRTSQ / Gritstone bio, Inc.
|
|
|
|
|
|
|
|